American Migraine Prevention Study

Nutritional Based Protocol to Balance Serotonin for the Prevention or Reduced Frequency/Duration/Intensity of Migraines

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00363506

Enrollment

1000

Registered

2006-08-15

Start date

2006-01-31

Completion date

2008-12-31

Last updated

2008-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine Disorders

Keywords

nutritional, C10.228.140.546.399.750

Brief summary

The purpose of this study is to evaluate the use of nutritional supplementation and dietary management for the reduction in frequency, duration, and intensity of migraine headache pain.

Detailed description

AMPS, the American Migraine Prevention Study Program is a home based nutritional study for migraine prevention. It is designed to evaluate a nutritional supplement along with proper diet, and trigger management that may prevent migraines or reduce the frequency, duration and intensity of migraine headache pain. The AMPS Program is availalbe nationwide. It is a home based study program. During the three month study period, participants will be asked to take a daily nutritional supplement and follow a recommended diet to avoid potential migraine triggers. Participants will be asked to maintain a headache log and submit headache questionnaires at the beginning and end of the study. Participants do not have to travel and can participate from their current location.

Interventions

BEHAVIORALSerotona Plus and dietary behavior management

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

PREVENTION

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to 72 Years

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of migraines * Ages 18-72 * Migraines more than once per month * Diagnosed migraines for more than one year

Exclusion criteria

* Pregnant/nursing

Design outcomes

Primary

Measure	Time frame
Migraine Impact and Disability Survey (MIDAS) - symptoms measured at study beginning and at 90 days	—

Countries

United States

Contacts

Primary ContactJohn J Carvalho, MBA

jjc@dynamichealthresources.com757-721-7781

Backup ContactKatherine huffman, MA

Katherine@dynamichealthresources.com571-334-9154

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026